↓ Skip to main content

Cell Division Machinery and Disease

Overview of attention for book
Attention for Chapter 6: Clinical Development of Anti-mitotic Drugs in Cancer
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Clinical Development of Anti-mitotic Drugs in Cancer
Chapter number 6
Book title
Cell Division Machinery and Disease
Published in
Advances in experimental medicine and biology, June 2017
DOI 10.1007/978-3-319-57127-0_6
Pubmed ID
Book ISBNs
978-3-31-957125-6, 978-3-31-957127-0
Authors

Olziersky, Anna-Maria, Labidi-Galy, S. Intidhar, Anna-Maria Olziersky, S. Intidhar Labidi-Galy

Editors

Monica Gotta, Patrick Meraldi

Abstract

Mitosis is one of the most fundamental processes of life by which a mammalian cell divides into two daughter cells. Mitosis has been an attractive target for anticancer therapies since fast proliferation was identified as one of the hallmarks of cancer cells. Despite efforts into developing specific inhibitors for mitotic kinases and kinesins, very few drugs have shown the efficiency of microtubule targeting-agents in cancer cells with paclitaxel being the most successful. A deeper translational research accompanying clinical trials of anti-mitotic drugs will help in identifying potent biomarkers predictive for response. Here, we review the current knowledge of mitosis targeting agents that have been tested so far in the clinics.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 23%
Student > Master 6 20%
Researcher 3 10%
Student > Bachelor 1 3%
Student > Doctoral Student 1 3%
Other 3 10%
Unknown 9 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 23%
Agricultural and Biological Sciences 5 17%
Medicine and Dentistry 4 13%
Chemistry 2 7%
Economics, Econometrics and Finance 1 3%
Other 3 10%
Unknown 8 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2017.
All research outputs
#20,427,593
of 22,979,862 outputs
Outputs from Advances in experimental medicine and biology
#3,983
of 4,957 outputs
Outputs of similar age
#275,730
of 317,056 outputs
Outputs of similar age from Advances in experimental medicine and biology
#97
of 122 outputs
Altmetric has tracked 22,979,862 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,957 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,056 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.